Venclexta Win Broadens AbbVie/Genentech CLL Positions

AbbVie Inc. just won approval to market a drug to compete with, well, one of its own medicines, sort of.

formula

AbbVie Inc. just won approval to market a drug to compete with, well, one of its own medicines, sort of.

The FDA on April 11 gave its blessing for the company to sell Venclexta (venetoclax), a small-molecule BCL-2 inhibitor, in...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Cardiovascular

More from Therapeutic Category